Stock Analysis

Asian Growth Companies With High Insider Ownership In June 2025

SEHK:1477
Source: Shutterstock

As of June 2025, the Asian markets are navigating a complex landscape marked by geopolitical tensions and evolving trade dynamics, with recent developments between China and the U.S. offering some optimism amid broader deflationary pressures in China. In this context, growth companies with high insider ownership can be particularly appealing to investors seeking stability and alignment of interests during uncertain times.

Advertisement

Top 10 Growth Companies With High Insider Ownership In Asia

NameInsider OwnershipEarnings Growth
Zhejiang Leapmotor Technology (SEHK:9863)15.6%59.9%
Vuno (KOSDAQ:A338220)15.6%109.8%
Suzhou Sunmun Technology (SZSE:300522)35.4%77.7%
Shanghai Huace Navigation Technology (SZSE:300627)24.3%23.5%
Schooinc (TSE:264A)30.6%68.9%
Samyang Foods (KOSE:A003230)11.7%24.3%
Oscotec (KOSDAQ:A039200)21.1%94.4%
M31 Technology (TPEX:6643)30.8%63.4%
Laopu Gold (SEHK:6181)35.5%40.3%
Fulin Precision (SZSE:300432)13.6%43%

Click here to see the full list of 609 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Ocumension Therapeutics (SEHK:1477)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Ocumension Therapeutics is an ophthalmic pharmaceutical platform company operating in the People's Republic of China, with a market cap of HK$8.22 billion.

Operations: The company's revenue segment focuses on the discovery, development, and commercialization of ophthalmic therapies, generating CN¥417.31 million.

Insider Ownership: 20.6%

Revenue Growth Forecast: 30.4% p.a.

Ocumension Therapeutics, with substantial insider ownership, is poised for significant growth. Its revenue is expected to grow at 30.4% annually, outpacing the Hong Kong market's 8.2%. Despite recent shareholder dilution and a volatile share price, earnings are forecasted to increase by over 100% per year. The company recently received approval for its OT-703 product in China’s Boao Lecheng zone and continues to expand its presence in Asia through strategic licensing agreements.

SEHK:1477 Ownership Breakdown as at Jun 2025
SEHK:1477 Ownership Breakdown as at Jun 2025

Henan Shijia Photons Technology (SHSE:688313)

Simply Wall St Growth Rating: ★★★★★★

Overview: Henan Shijia Photons Technology Co., Ltd. (SHSE:688313) operates in the photonics industry with a market cap of CN¥16.67 billion.

Operations: Henan Shijia Photons Technology generates revenue primarily from its Optical Networking Equipments segment, which amounts to CN¥1.31 billion.

Insider Ownership: 10.1%

Revenue Growth Forecast: 28.0% p.a.

Henan Shijia Photons Technology, with significant insider ownership, is experiencing robust growth. The company's revenue and earnings are forecasted to grow at 28% and 40.2% annually, respectively, surpassing the broader Chinese market's growth rates. Recent financial results showed a dramatic increase in net income from CNY 8.44 million to CNY 93.19 million year-over-year for Q1 2025. Despite a highly volatile share price recently, its return on equity is expected to reach high levels in three years.

SHSE:688313 Ownership Breakdown as at Jun 2025
SHSE:688313 Ownership Breakdown as at Jun 2025

Luoyang Xinqianglian Slewing Bearing (SZSE:300850)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Luoyang Xinqianglian Slewing Bearing Co., Ltd. operates in the manufacturing sector, specializing in the production of slewing bearings, with a market cap of CN¥13.65 billion.

Operations: Revenue Segments: The company generates its income primarily from the manufacturing of slewing bearings, contributing significantly to its financial performance.

Insider Ownership: 34.2%

Revenue Growth Forecast: 18.3% p.a.

Luoyang Xinqianglian Slewing Bearing demonstrates strong growth potential, with earnings forecasted to grow at 29.61% annually, outpacing the Chinese market's 23.2%. Despite a recent decrease in dividends and a decline in net income from CNY 374.84 million to CNY 65.38 million for the full year, Q1 2025 results showed significant recovery with net income rising to CNY 170.48 million from a loss of CNY 51.77 million year-over-year.

SZSE:300850 Earnings and Revenue Growth as at Jun 2025
SZSE:300850 Earnings and Revenue Growth as at Jun 2025

Summing It All Up

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com